{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:40:37Z","timestamp":1767912037336,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013133","name":"Mundipharma AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007622","name":"Australian Education International, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1041472"],"award-info":[{"award-number":["1041472"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.drugalcdep.2019.06.035","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T11:38:50Z","timestamp":1571744330000},"page":"107533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids"],"prefix":"10.1016","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8609-0075","authenticated-orcid":false,"given":"Amanda","family":"Roxburgh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1984-0096","authenticated-orcid":false,"given":"Wayne D.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0452-8470","authenticated-orcid":false,"given":"Natasa","family":"Gisev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8513-2218","authenticated-orcid":false,"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0005","series-title":"1216.0 - Australian Standard Geographical Classification (ASGC)","author":"Australian Bureau of Statistics","year":"2011"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","article-title":"Today\u2019s fentanyl crisis: prohibition\u2019s Iron law, revisited","volume":"46","author":"Beletsky","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.ajp.2011.10101476","article-title":"Risk of death from accidental overdose associated with psychiatric and substance use disorders","volume":"169","author":"Bohnert","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MLR.0000000000000505","article-title":"A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain","volume":"54","author":"Bohnert","year":"2016","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40621-017-0118-7","article-title":"Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis","volume":"4","author":"Brady","year":"2017","journal-title":"Inj. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/AJP.0000000000000283","article-title":"Prevalence and correlates of suicidal thoughts and suicide attempts in people prescribed pharmaceutical opioids for chronic pain","volume":"32","author":"Campbell","year":"2016","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0035","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/pme.12773","article-title":"Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the pain and opioids in treatment (POINT) cohort","volume":"16","author":"Campbell","year":"2015","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","article-title":"Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs","volume":"162","author":"Caudarella","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0045","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1111\/j.1526-4637.2011.01131.x","article-title":"Depression, chronic pain, and suicide by overdose: on the edge","volume":"12","author":"Cheatle","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0055","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States. A retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0065","series-title":"The Life of the Heroin User; Typical Beginnings Trajectories and Outcomes","author":"Darke","year":"2011"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2010.10.021","article-title":"Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009","volume":"115","author":"Darke","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: No easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3122\/jabfm.2017.04.170112","article-title":"Prescription opioid use among adults with mental health disorders in the United States","volume":"30","author":"Davis","year":"2017","journal-title":"J. Am. Board Fam. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jpain.2015.12.006","article-title":"Risk Factors of Prescription Opioid Overdose Among Colorado Medicaid Beneficiaries","volume":"17","author":"Dilokthornsakul","year":"2016","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0095","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0100","series-title":"European Drug Report 2018","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0105","series-title":"Fentanils and Synthetic Cannabinoids: Driving Greater Complexity into the Drug Situation; An Update From the EU Early Warning System","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugpo.2008.02.016","article-title":"Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications","volume":"20","author":"Firestone","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0115","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1503\/cmaj.160356","article-title":"Effective Canadian policy to reduce harms from prescription opioids: learning from past failures","volume":"188","author":"Fischer","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ypmed.2017.11.001","article-title":"The\u2019 fentanyl epidemic\u2019 in Canada - some cautionary observations focusing on opioid-related mortality","volume":"107","author":"Fischer","year":"2018","journal-title":"Prev. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/add.13925","article-title":"Risk factors for severe respiratory depression from prescription opioid overdose","volume":"113","author":"Fox","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.sapharm.2017.04.002","article-title":"A nationwide study of the extent and factors associated with fentanyl use in Australia","volume":"14","author":"Gisev","year":"2018","journal-title":"Res. Social Adm. Pharm."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0135","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0140","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jamainternmed.2013.12711","article-title":"High-risk use by patients prescribed opioids for pain and its role in overdose deaths","volume":"174","author":"Gwira Baumblatt","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0145","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","article-title":"Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities","volume":"300","author":"Hall","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0150","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2016","author":"Hedegaard","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1526-4637.2012.01527.x","article-title":"An evaluation of the prescription of opioids for chronic nonmalignant pain by Australian general practitioners","volume":"14","author":"Holliday","year":"2013","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000312","article-title":"High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System","volume":"11","author":"Hser","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.15585\/mmwr.mm6526a2","article-title":"Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths - United States, 2002-2014","volume":"65","author":"Jones","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0170","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.12937","article-title":"Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims","author":"Karanges","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0175","series-title":"Karch\u2019s Pathology of Drug Abuse","author":"Karch","year":"2009"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0180","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2105\/AJPH.2013.301709","article-title":"Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States","volume":"104","author":"Keyes","year":"2014","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0185","article-title":"Harms associated with extramedical use of prescription opioid analgesics in Australia: A scoping review","author":"Lalic","year":"2018","journal-title":"Res. Social Adm. Pharm."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0190","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/j.1526-4637.2012.01518.x","article-title":"Risk factors for prescription opioid-related death, Utah, 2008-2009","volume":"13","author":"Lanier","year":"2012","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1465-3362.2010.00283.x","article-title":"Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours","volume":"30","author":"Larance","year":"2011","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugpo.2016.08.004","article-title":"Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre","volume":"37","author":"Latimer","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0205","article-title":"Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis","author":"Ma","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060600","article-title":"Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada","volume":"8","author":"Madadi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0215","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2105\/AJPH.2015.302843","article-title":"Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2471\/BLT.12.108282","article-title":"Mortality among people who inject drugs: a systematic review and meta-analysis","volume":"91","author":"Mathers","year":"2013","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0225","article-title":"An acetyl fentanyl death in Western Australia","author":"Moss","year":"2017","journal-title":"Aust. J. Forensic Sci."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1465-3362.2011.00302.x","article-title":"Pharmaceutical opioid analgesic and heroin depdendence: how do treatment-seeking clients differ in Australia?","volume":"30","author":"Nielsen","year":"2011","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.drugalcdep.2015.02.004","article-title":"Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011","volume":"149","author":"Nielsen","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0240","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMp1801417","article-title":"Suicide: a silent contributor to opioid-overdose deaths","volume":"378","author":"Oquendo","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0245","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pds.1276","article-title":"Increasing deaths from opioid analgesics in the United States","volume":"15","author":"Paulozzi","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0250","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MLR.0000000000000944","article-title":"Overview of prescription opioid deaths in the Oklahoma State Medicaid Population, 2012-2016","volume":"56","author":"Pham","year":"2018","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0773.1994.tb01068.x","article-title":"Liposolubility and protein binding of oxycodone in vitro","volume":"74","author":"Poyhia","year":"1994","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0260","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/jat\/bkx013","article-title":"A cluster of fentanyl-laced heroin deaths in 2015 in Melbourne, Australia","volume":"41","author":"Rodda","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0265","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2017.02.027","article-title":"Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre","volume":"176","author":"Roxburgh","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0270","series-title":"Opioid-, amphetamine-, and cocaine-induced deaths in Australia","author":"Roxburgh","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0275","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5694\/mja15.00183","article-title":"Trends and characteristics of accidental and intentional codeine overdose deaths in Australia","volume":"203","author":"Roxburgh","year":"2015","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0280","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.drugalcdep.2017.07.018","article-title":"Trends in heroin and pharmaceutical opioid overdose deaths in Australia","volume":"179","author":"Roxburgh","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0285","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.forsciint.2018.03.032","article-title":"Accurate identification of opioid overdose deaths using coronial data","volume":"287","author":"Roxburgh","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0290","series-title":"Prescription Opioid Policy: Improving Management of Chronic Non-malignant Pain and Prevention of Problems Associated With Prescription Opioid Use","author":"Royal Australasian College of Physicians","year":"2009"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0295","series-title":"Base SAS\u00ae 9.4","author":"SAS Institute Inc","year":"2016"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0300","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/PSY.0b013e3181e3333d","article-title":"Chronic physical conditions and their association with first onset of suicidal behavior in the world mental health surveys","volume":"72","author":"Scott","year":"2010","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0305","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0310","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpain.2014.08.010","article-title":"The fentanyl story","volume":"15","author":"Stanley","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0315","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1465-3362.2009.00057.x","article-title":"Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data","volume":"28","author":"Stoove","year":"2009","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0320","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1017\/S0033291705006859","article-title":"Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links","volume":"36","author":"Tang","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0325","series-title":"Final Decisions and Reasons for Decisions by Delegates of the Secretary to the Department of Health","author":"Therapeutic Goods Administration","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0330","series-title":"Scheduling Delegate\u2019s Final Decision: Codeine","author":"Therapeutic Goods Administration","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0335","series-title":"eTG Complete","author":"Therapeutic Guidelines Limited","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0340","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11606-015-3199-4","article-title":"Drug overdose in a retrospective cohort with non-cancer pain treated with opioids, antidepressants, and\/or sedative-hypnotics: interactions with mental health disorders","volume":"30","author":"Turner","year":"2015","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0345","first-page":"37","article-title":"Characteristics of methadone-related overdose deaths and comparisons between those dying on and off opioid agonist treatment (OAT): a national cohort study","volume":"20","author":"Van Hout","year":"2018","journal-title":"Heroin Addict. Relat. Clin. Probl."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0350","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"Suppl","key":"10.1016\/j.drugalcdep.2019.06.035_bib0355","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.drugalcdep.2004.08.003","article-title":"Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies","volume":"76","author":"Wilcox","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0360","series-title":"The International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10)","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0365","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpain.2015.01.475","article-title":"Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in medicaid","volume":"16","author":"Yang","year":"2015","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0370","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/02024458-201512000-00004","article-title":"The rise of overdose deaths involving fentanyl and the value of early warning","volume":"6","author":"Young","year":"2015","journal-title":"Can. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0375","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/pm\/pnx009","article-title":"Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database","volume":"19","author":"Zedler","year":"2018","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2019.06.035_bib0380","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/pme.12480","article-title":"Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients","volume":"15","author":"Zedler","year":"2014","journal-title":"Pain Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619302923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619302923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:04:41Z","timestamp":1759827881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619302923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":76,"alternative-id":["S0376871619302923"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.035","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107533"}}